Nektar Therapeutics Up 83.2% Since SmarTrend's Buy Recommendation
Do you know when to trade NKTR ?
NKTR | Quote | Chart | News | PowerRating -- SmarTrend, our proprietary pattern recognition system, called an Uptrend for Nektar Therapeutics (NASDAQ:NKTR) on March 25, 2009 at $5.13.
Since then, Nektar Therapeutics has returned 83.2% as of Friday's recent price of $9.40. Want to profit from these alerts?
Go to www.mysmartrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
For full details on Nektar Therapeutics (NKTR) NKTR. Nektar Therapeutics (NKTR) has Short Term PowerRatings at TradingMarkets. Details on Nektar Therapeutics (NKTR) Short Term PowerRatings is available at This Link.
- Quadruple Witching & 3 PowerRatings Stocks - 03/18/10
- Nektar reports positive results from Phase II ovarian cancer trial - 03/09/10
- Nektar Announces Positive Phase 2 Clinical Data from First Stage of NKTR-102 Study in Women with Platinum-Resistant Ovarian Canc - 03/08/10
- Nektar Therapeutics Finished At New High For Year Wednesday - 03/04/10
- Nektar Therapeutics (NKTR) Corporate Event Announcement Notice - 03/03/10
- More News >>


